Cargando…
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study
OBJECTIVE: To estimate the risk of non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma (HL) in patients with inflammatory bowel disease (IBD). DESIGN: We undertook a two-country population cohort study with all patients diagnosed with IBD in Norway and Sweden from 1987 and 1993 through 2015 and 2016...
Autores principales: | Yu, Jingru, Refsum, Erle, Wieszczy, Paulina, Helsingen, Lise M, Perrin, Vera, Högdén, Amanda, Løberg, Magnus, Blom, Johannes, Bretthauer, Michael, Adami, Hans-Olov, Ye, Weimin, Kalager, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163486/ https://www.ncbi.nlm.nih.gov/pubmed/37142293 http://dx.doi.org/10.1136/bmjgast-2022-001037 |
Ejemplares similares
-
Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study
por: Yu, Jingru, et al.
Publicado: (2022) -
The COVID-19 pandemic in Norway and Sweden – threats, trust, and impact on daily life: a comparative survey
por: Helsingen, Lise M., et al.
Publicado: (2020) -
Reply to: Letter to the Editor regarding "Covid-19 transmission in fitness centers in Norway—a randomized trial"
por: Helsingen, Lise M., et al.
Publicado: (2022) -
Mortality in Norway and Sweden during the COVID-19 pandemic
por: Juul, Frederik E., et al.
Publicado: (2021) -
Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models
por: Wieszczy, Paulina, et al.
Publicado: (2021)